Nuestros recursos

The FDA’s PFDD guidance series is a much-needed update to the PRO guidance released in 2009. But, what do these new recommendations mean for electronic data capture in clinical trials? Here’s what you need to know.

In this webinar, our expert panelists address the challenges and opportunities associated with sensors and wearables in clinical research—and how sponsors and study teams can incorporate these instruments to maximize the signal-to-noise ratio, increase patient comfort, and generate stronger, more robust evidence. Download the webinar summary and key takeaways in PDF format by filling out the form below.

Artificial intelligence (AI) is transforming the landscape of patient engagement in clinical trials. Here’s everything you need to know.

Inc. Magazine today ranked ObvioHealth, a global virtual research organization (VRO) pioneering tech-enabled clinical trials, number 962 on its annual list of the nation’s fastest-growing private companies. ObvioHealth has now been named on Inc. 5000’s premier list for the third consecutive year.

A comprehensive guide to patient-first study design strategies that deliver stronger evidence